BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...
Power and Progress: PECO’s Bold Plan for a More Resilient Energy Grid
A $9.3 billion investment aims to strengthen our energy infrastructure for increased demand and extreme weather while ...